SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-12-004003
Filing Date
2012-04-06
Accepted
2012-04-06 15:56:49
Documents
4
Period of Report
2012-05-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2208724zpre14a.htm PRE 14A 1097540
2 G817752.JPG g817752.jpg GRAPHIC 6750
3 G14702BCI001.GIF g14702bci001.gif GRAPHIC 50804
4 G14702BEI001.GIF g14702bei001.gif GRAPHIC 73062
  Complete submission text file 0001047469-12-004003.txt   1279027
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-30319 | Film No.: 12748281
SIC: 2834 Pharmaceutical Preparations